Cytognos is a Biotech company based in Salamanca with over 20 years of experience at successfully designing, developing, manufacturing and commercializing innovative flow cytometry products for in vitro diagnostics (IVD) and life science research use only (RUO). Cytognos´ growth strategy has been based on bringing to the market exclusive technologies transferred by research centres and universities, these innovative products have allowed Cytognos to become a reference point, providing world-class products developed to address gaps within the current multicolour flow cytometry workflow. Cytognos collaborates actively with the EuroFlow™ consortium implementing and bringing onto the market the Next Generation Flow™ approach which provides high sensitive flow cytometry tests and standardized protocols for the diagnosis, classification and follow-up of haematological malignancies, Minimal Residual Disease detection and Primary Immunodeficiencies.